Clinical Trial Update: Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of food on the pharmacokinetics of a single oral dose of cediranib (AZD2171, Recentin). Results were posted in 2012…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Cediranib (AZD2171, Recentin) (cediranib)

Snippet

Sponsor: AstraZeneca | Conditions: Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-11-01